Nonalcoholic Fatty Liver Disease clinical trials in California
18 active Nonalcoholic Fatty Liver Disease trials with a site in California. Describe your situation to see which ones look like a fit.
- A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
- A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
- A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
- Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
- Accurate Point of Care Liver Disease Diagnostics (Phase 2)
- Pediatric Metabolic Dysfunction-associated Steatotic Liver Disease and Food Insecurity
- Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
- Androgens and NAFLD Longitudinal Cohort Study
- NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease
- Food Insecurity and MASLD: A Fruit and Vegetable Intervention Study
- Time-restricted Eating and Healthy Eating in Patients With Metabolic Liver Disease or Cancer
- Implementing Food Referrals for Equity and Sustained Health
- Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)
- Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions
- A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.